Kawasaki, Japan

Katsuhiko Miyazawa


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1987-1990

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Katsuhiko Miyazawa

Introduction

Katsuhiko Miyazawa is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as lipoxygenase inhibitors. With a total of three patents to his name, his work has implications for the treatment of various medical conditions.

Latest Patents

Miyazawa's latest patents include innovative compounds that demonstrate potential therapeutic benefits. One of his notable inventions is a compound known as 2-(3,5-dimethyl-4-hydroxyphenyl)indole derivatives. This compound is characterized by a specific formula where R1 can be a hydrogen atom or a methoxy group, and A represents a C1-C4 alkylene group. This compound is particularly useful as a medicine, especially as a lipoxygenase inhibitor for polyunsaturated fatty acids. Another significant patent is for 2-(3,5-dialkyl-4-hydroxyphenyl)indole derivatives. This compound has a complex structure and exhibits 5-lipoxygenase inhibiting activity, making it valuable as a medicament.

Career Highlights

Miyazawa is currently associated with Teikoku Hormone Mfg. Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing the understanding and application of lipoxygenase inhibitors in medicine.

Collaborations

Miyazawa has collaborated with esteemed colleagues such as Yasushi Suzuki and Yukio Hasegawa. These partnerships have contributed to the successful development of his patented compounds.

Conclusion

Katsuhiko Miyazawa's contributions to medicinal chemistry through his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…